COMMUNIQUÉS West-GlobeNewswire

-
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
10/07/2025 -
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
10/07/2025 -
e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data
10/07/2025 -
TerrAscend to Host Second Quarter 2025 Earnings Conference Call
10/07/2025 -
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
10/07/2025 -
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
10/07/2025 -
New Bay Area Lyme Foundation Study Reports That Only One-Third of Early Lyme Patients with On-Going Symptoms Followed up with their Healthcare Providers
10/07/2025 -
Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
10/07/2025 -
Epitopea renforce ses capacités de recherche et de développement clinique pour accélérer le passage à la clinique
10/07/2025 -
Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
10/07/2025 -
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
10/07/2025 -
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
10/07/2025 -
Osivax Publishes Phase 2a Results Supporting Co-Administration of OVX836 with Seasonal Flu Vaccine in Vaccines Journal
10/07/2025 -
Tecan announces CEO transition as part of succession planning
10/07/2025 -
DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project
10/07/2025 -
Gozellix Receives Permanent HCPCS Code
10/07/2025 -
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
09/07/2025 -
HNL Lab Medicine Named Empowering Women Award Recipient for 2025
09/07/2025 -
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
09/07/2025
Pages